tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Vor Bio appoints Osovsky as General Counsel
The FlyVor Bio appoints Osovsky as General Counsel
7d ago
VOR
ITOS
iTeos Therapeutics Completes Merger with Concentra Biosciences
PremiumCompany Announcements
iTeos Therapeutics Completes Merger with Concentra Biosciences
11d ago
8K
ITOS
GSK and iTeos Advance Immunotherapy Study for Lung Cancer
PremiumCompany Announcements
GSK and iTeos Advance Immunotherapy Study for Lung Cancer
25d ago
GSK
ITOS
GSK and iTeos Therapeutics’ Promising Phase 3 Lung Cancer Study: Market Implications
PremiumCompany Announcements
GSK and iTeos Therapeutics’ Promising Phase 3 Lung Cancer Study: Market Implications
1M ago
GSK
ITOS
iTeos Therapeutics Faces Challenges Amid Collaboration Termination
PremiumCompany Announcements
iTeos Therapeutics Faces Challenges Amid Collaboration Termination
1M ago
ITOS
iTeos Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyiTeos Therapeutics downgraded to Neutral from Overweight at Piper Sandler
2M ago
ITOS
Vor Bio appoints Cumbo, Detheux to board of directors
Premium
The Fly
Vor Bio appoints Cumbo, Detheux to board of directors
2M ago
VOR
ITOS
iTeos Therapeutics Announces Merger with Concentra Biosciences
Premium
Company Announcements
iTeos Therapeutics Announces Merger with Concentra Biosciences
2M ago
8K
ITOS
iTeos to be acquired by Concentra for $10.047 per share in cash plus CVR
PremiumThe Fly
iTeos to be acquired by Concentra for $10.047 per share in cash plus CVR
2M ago
ITOS
GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment
PremiumCompany Announcements
GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment
2M ago
GSK
ITOS
GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab
PremiumCompany Announcements
GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab
2M ago
GSK
ITOS
iTeos Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
iTeos Therapeutics Holds Annual Stockholders Meeting
3M ago
8K
ITOS
Tim Van Hauwermeiren Resigns from iTeos Board
PremiumCompany AnnouncementsTim Van Hauwermeiren Resigns from iTeos Board
3M ago
8K
ITOS
iTeos Therapeutics: Strategic Wind Down to Maximize Shareholder Value Amid Limited Pipeline Prospects
Premium
Ratings
iTeos Therapeutics: Strategic Wind Down to Maximize Shareholder Value Amid Limited Pipeline Prospects
3M ago
ITOS
iTeos Therapeutics downgraded to Equal Weight at Wells Fargo on wind down
Premium
The Fly
iTeos Therapeutics downgraded to Equal Weight at Wells Fargo on wind down
3M ago
ITOS
iTeos Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
iTeos Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
3M ago
ITOS
iTeos Therapeutics Stock (ITOS) Booms 24% as it Winds Down and Sells Cancer Treatments
PremiumMarket News
iTeos Therapeutics Stock (ITOS) Booms 24% as it Winds Down and Sells Cancer Treatments
3M ago
ITOS
iTeos Therapeutics downgraded to Neutral at Wedbush after wind down decision
PremiumThe Fly
iTeos Therapeutics downgraded to Neutral at Wedbush after wind down decision
3M ago
ITOS
iTeos Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
iTeos Therapeutics downgraded to Neutral from Outperform at Wedbush
3M ago
ITOS
iTeos Therapeutics Announces Strategic Wind Down Plan
PremiumCompany AnnouncementsiTeos Therapeutics Announces Strategic Wind Down Plan
3M ago
8K
ITOS
iTeos Therapeutics announces intention to wind down operations
Premium
The Fly
iTeos Therapeutics announces intention to wind down operations
3M ago
ITOS
iTeos Therapeutics price target lowered to $13 from $16 at Wells Fargo
Premium
The Fly
iTeos Therapeutics price target lowered to $13 from $16 at Wells Fargo
4M ago
ITOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >